U.S. flag

An official website of the United States government

GTR Home > Laboratories > Myriad Genetics, Inc.

Myriad Genetics, Inc.

GTR Lab ID: 507240, Last updated:2023-01-13

Personnel

Conditions and tests

  • 3-Methylglutaconic aciduria type 32 tests
  • 4p partial monosomy syndrome1 test
  • 5p partial monosomy syndrome1 test
  • 6-Pyruvoyl-tetrahydrobiopterin synthase deficiency1 test
  • Achondrogenesis, type IB1 test
  • Achromatopsia1 test
  • Adrenoleukodystrophy1 test
  • Agenesis of the corpus callosum with peripheral neuropathy2 tests
  • ALG6-congenital disorder of glycosylation 1C1 test
  • Alkaptonuria1 test
  • alpha Thalassemia1 test
  • Alpha-1-antitrypsin deficiency1 test
  • Alstrom syndrome1 test
  • Angelman syndrome1 test
  • Angiokeratoma corporis diffusum1 test
  • Arginase deficiency1 test
  • Argininosuccinate lyase deficiency1 test
  • Aspartylglucosaminuria2 tests
  • Ataxia-telangiectasia syndrome2 tests
  • Autosomal dominant nonsyndromic hearing loss 111 test
  • Autosomal recessive Alport syndrome2 tests
  • Autosomal recessive congenital ichthyosis 11 test
  • Autosomal recessive distal spinal muscular atrophy 11 test
  • Autosomal recessive distal spinal muscular atrophy 21 test
  • Autosomal recessive DOPA responsive dystonia2 tests
  • Autosomal recessive limb-girdle muscular dystrophy type 2A1 test
  • Autosomal recessive limb-girdle muscular dystrophy type 2B1 test
  • Autosomal recessive limb-girdle muscular dystrophy type 2C1 test
  • Autosomal recessive limb-girdle muscular dystrophy type 2D2 tests
  • Autosomal recessive limb-girdle muscular dystrophy type 2E1 test
  • Autosomal recessive limb-girdle muscular dystrophy type 2F1 test
  • Autosomal recessive limb-girdle muscular dystrophy type 2I1 test
  • Autosomal recessive limb-girdle muscular dystrophy type 2M1 test
  • Autosomal recessive lower motor neuron disease with childhood onset1 test
  • Autosomal recessive nonsyndromic hearing loss 18A1 test
  • Autosomal recessive nonsyndromic hearing loss 1A2 tests
  • Autosomal recessive nonsyndromic hearing loss 21 test
  • Autosomal recessive nonsyndromic hearing loss 231 test
  • Autosomal recessive osteopetrosis 11 test
  • Autosomal recessive polycystic kidney disease2 tests
  • AXIN2-related attenuated familial adenomatous polyposis2 tests
  • BAP1-related tumor predisposition syndrome2 tests
  • Bardet-Biedl syndrome 12 tests
  • Bardet-Biedl syndrome 102 tests
  • Bardet-Biedl syndrome 121 test
  • Bardet-Biedl syndrome 131 test
  • Bardet-Biedl syndrome 21 test
  • Becker muscular dystrophy1 test
  • beta Thalassemia2 tests
  • Bifunctional peroxisomal enzyme deficiency2 tests
  • Biotinidase deficiency2 tests
  • Bloom syndrome2 tests
  • Breast neoplasm4 tests
  • Breast-ovarian cancer, familial, susceptibility to, 11 test
  • Carcinoma of colon1 test
  • Carnitine palmitoyl transferase 1A deficiency2 tests
  • Carnitine palmitoyltransferase II deficiency2 tests
  • Ceroid lipofuscinosis, neuronal, 6A1 test
  • Cetuximab response1 test
  • Charlevoix-Saguenay spastic ataxia2 tests
  • Cholestanol storage disease1 test
  • Choroideremia1 test
  • Chromosome 1p36 deletion syndrome1 test
  • Citrullinemia type I2 tests
  • Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency1 test
  • Classic homocystinuria2 tests
  • Cobalamin C disease1 test
  • Cockayne syndrome type 11 test
  • Cockayne syndrome type 21 test
  • Cohen syndrome2 tests
  • Colorectal carcinoma1 test
  • Complete trisomy 13 syndrome1 test
  • Complete trisomy 20 syndrome1 test
  • Complete trisomy 21 syndrome1 test
  • Congenital adrenal hyperplasia2 tests
  • Congenital adrenal hypoplasia, X-linked1 test
  • Congenital hyperammonemia, type I1 test
  • Congenital lactic acidosis, Saguenay-Lac-Saint-Jean type1 test
  • Congenital lipoid adrenal hyperplasia due to STAR deficency1 test
  • Cutis laxa, X-linked1 test
  • Cystic fibrosis3 tests
  • Cystinosis1 test
  • Dabrafenib response1 test
  • Deficiency of alpha-mannosidase2 tests
  • Deficiency of butyryl-CoA dehydrogenase2 tests
  • Deficiency of butyrylcholinesterase1 test
  • Deficiency of galactokinase1 test
  • Deficiency of hydroxymethylglutaryl-CoA lyase1 test
  • Deficiency of steroid 11-beta-monooxygenase1 test
  • Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase2 tests
  • Diastrophic dysplasia1 test
  • Dihydropyrimidine dehydrogenase deficiency1 test
  • Dilated cardiomyopathy 1L1 test
  • Dilated cardiomyopathy 3B1 test
  • Distal monosomy 10p1 test
  • Distal spinal muscular atrophy type 31 test
  • Double Y syndrome1 test
  • Duchenne muscular dystrophy1 test
  • Dyskeratosis congenita, autosomal recessive 51 test
  • EGFR inhibitors response1 test
  • EGFR-related lung cancer2 tests
  • Ellis-van Creveld syndrome2 tests
  • Endometrial carcinoma2 tests
  • Erlotinib response1 test
  • Familial adenomatous polyposis 13 tests
  • Familial adenomatous polyposis 22 tests
  • Familial cancer of breast1 test
  • Familial colorectal cancer2 tests
  • Familial dysautonomia2 tests
  • Familial hyperinsulinism1 test
  • Familial idiopathic steroid-resistant nephrotic syndrome1 test
  • Familial isolated deficiency of vitamin E2 tests
  • Familial Mediterranean fever2 tests
  • Familial medullary thyroid carcinoma2 tests
  • Familial melanoma2 tests
  • Familial pancreatic carcinoma2 tests
  • Familial prostate carcinoma2 tests
  • Fanconi anemia complementation group A1 test
  • Fanconi anemia complementation group C2 tests
  • Finnish congenital nephrotic syndrome2 tests
  • Fragile X syndrome2 tests
  • Fulvestrant response1 test
  • Galactosylceramide beta-galactosidase deficiency2 tests
  • Gaucher disease1 test
  • Gaucher disease perinatal lethal1 test
  • Gaucher disease type II1 test
  • Gaucher disease type III1 test
  • Gefitinib response1 test
  • Glucose-6-phosphate transport defect2 tests
  • Glutaric aciduria, type 12 tests
  • Glycogen storage disease due to glucose-6-phosphatase deficiency type IA2 tests
  • Glycogen storage disease type III2 tests
  • Glycogen storage disease, type II2 tests
  • Glycogen storage disease, type V1 test
  • GM1 gangliosidosis type 21 test
  • GM1 gangliosidosis type 31 test
  • GNE myopathy2 tests
  • GNPTG-mucolipidosis1 test
  • GRACILE syndrome2 tests
  • Hb SS disease2 tests
  • Hemoglobin H disease, nondeletional1 test
  • Hereditary breast ovarian cancer syndrome4 tests
  • Hereditary diffuse gastric adenocarcinoma2 tests
  • Hereditary factor XI deficiency disease1 test
  • Hereditary fructosuria2 tests
  • Hereditary hemochromatosis1 test
  • Hereditary nonpolyposis colon cancer3 tests
  • Hereditary papillary renal cell carcinoma2 tests
  • Hereditary Paraganglioma-Pheochromacytoma Syndrome1 test
  • Hereditary pheochromocytoma-paraganglioma1 test
  • Hereditary spastic paraplegia 151 test
  • Holocarboxylase synthetase deficiency1 test
  • Homocystinuria due to methylene tetrahydrofolate reductase deficiency1 test
  • Hurler syndrome1 test
  • Hydrolethalus syndrome1 test
  • Hypercoagulability1 test
  • Hyperinsulinemic hypoglycemia, familial, 12 tests
  • Hypophosphatasia2 tests
  • Infantile GM1 gangliosidosis1 test
  • Isovaleryl-CoA dehydrogenase deficiency2 tests
  • Joubert syndrome 22 tests
  • Junctional epidermolysis bullosa gravis of Herlitz4 tests
  • Junctional epidermolysis bullosa, non-Herlitz type3 tests
  • Juvenile polyposis syndrome2 tests
  • Juvenile retinoschisis2 tests
  • Klinefelter syndrome1 test
  • Lapatinib response1 test
  • Li-Fraumeni syndrome2 tests
  • Lipoamide dehydrogenase deficiency1 test
  • Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency1 test
  • Lysosomal acid lipase deficiency1 test
  • Malignant tumor of breast1 test
  • Malignant tumor of prostate1 test
  • Maple syrup urine disease type 1A1 test
  • Maple syrup urine disease type 1B2 tests
  • Maple syrup urine disease type 21 test
  • Meckel-Gruber syndrome1 test
  • Medium-chain acyl-coenzyme A dehydrogenase deficiency2 tests
  • Megalencephalic leukoencephalopathy with subcortical cysts2 tests
  • Megalencephalic leukoencephalopathy with subcortical cysts 11 test
  • Melanoma-pancreatic cancer syndrome2 tests
  • Menkes kinky-hair syndrome1 test
  • Merosin deficient congenital muscular dystrophy2 tests
  • Metachromatic leukodystrophy2 tests
  • Metaphyseal chondrodysplasia, McKusick type2 tests
  • Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency1 test
  • Methylmalonic aciduria, cblA type1 test
  • Methylmalonic aciduria, cblB type1 test
  • Microcephaly, normal intelligence and immunodeficiency2 tests
  • Mitochondrial trifunctional protein deficiency1 test
  • Miyoshi muscular dystrophy 11 test
  • Mosaic trisomy 11 test
  • Mosaic trisomy 21 test
  • Mosaic trisomy 31 test
  • Motor axonal neuropathy1 test
  • MPI-congenital disorder of glycosylation2 tests
  • Mucolipidosis type II1 test
  • Mucolipidosis type IV2 tests
  • Mucopolysaccharidosis type 11 test
  • Mucopolysaccharidosis, MPS-II1 test
  • Mucopolysaccharidosis, MPS-III-A1 test
  • Mucopolysaccharidosis, MPS-III-B1 test
  • Mucopolysaccharidosis, MPS-III-C1 test
  • Mucopolysaccharidosis, MPS-IV-B1 test
  • Multiple cutaneous leiomyomas2 tests
  • Multiple endocrine neoplasia1 test
  • Multiple endocrine neoplasia, type 11 test
  • Multiple endocrine neoplasia, type 21 test
  • Multiple epiphyseal dysplasia type 41 test
  • Multiple fibrofolliculomas2 tests
  • Muscle eye brain disease4 tests
  • Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 41 test
  • Nemaline myopathy 22 tests
  • Neoplasm of ovary1 test
  • Nephropathic cystinosis1 test
  • Nephrotic syndrome, type 21 test
  • Neuronal ceroid lipofuscinosis 12 tests
  • Neuronal ceroid lipofuscinosis 22 tests
  • Neuronal ceroid lipofuscinosis 32 tests
  • Neuronal ceroid lipofuscinosis 52 tests
  • Neuronal ceroid lipofuscinosis 81 test
  • Neuronal ceroid lipofuscinosis 8 northern epilepsy variant2 tests
  • Niemann-Pick disease, type A2 tests
  • Niemann-Pick disease, type B2 tests
  • Niemann-Pick disease, type C1 test
  • Niemann-Pick disease, type C11 test
  • Niemann-Pick disease, type C21 test
  • Non-ketotic hyperglycinemia2 tests
  • Olaparib response2 tests
  • Ornithine carbamoyltransferase deficiency1 test
  • Ovarian cancer1 test
  • Ovarian epithelial cancer1 test
  • Pancreatic cancer, adult1 test
  • Panitumumab response1 test
  • Pearson syndrome1 test
  • Pemigatinib response1 test
  • Pendred syndrome2 tests
  • Peroxisome biogenesis disorder1 test
  • Peroxisome biogenesis disorder 1A (Zellweger)2 tests
  • Peroxisome biogenesis disorder 1B1 test
  • Peroxisome biogenesis disorder 3A (Zellweger)1 test
  • Peroxisome biogenesis disorder 4A (Zellweger)1 test
  • Peroxisome biogenesis disorder 4B1 test
  • Peroxisome biogenesis disorder 5A (Zellweger)1 test
  • Peroxisome biogenesis disorder 5B1 test
  • Peroxisome biogenesis disorder 6A (Zellweger)1 test
  • Peroxisome biogenesis disorder 6B1 test
  • Peroxisome biogenesis disorder 9B1 test
  • Pertuzumab response1 test
  • Peutz-Jeghers syndrome2 tests
  • Phenylketonuria2 tests
  • Phytanic acid storage disease1 test
  • Pituitary hormone deficiency, combined, 22 tests
  • PMM2-congenital disorder of glycosylation2 tests
  • Polyglandular autoimmune syndrome, type 12 tests
  • Polymerase proofreading-related adenomatous polyposis2 tests
  • Polyposis syndrome, hereditary mixed, 12 tests
  • Prader-Willi syndrome1 test
  • Primary hyperoxaluria type 31 test
  • Primary hyperoxaluria, type I2 tests
  • Primary hyperoxaluria, type II2 tests
  • Propionic acidemia2 tests
  • Prostate cancer, somatic1 test
  • Pseudo-Hurler polydystrophy1 test
  • PTEN hamartoma tumor syndrome2 tests
  • Pyknodysostosis2 tests
  • Pyruvate carboxylase deficiency1 test
  • Pyruvate dehydrogenase E3 deficiency1 test
  • Qualitative or quantitative defects of beta-sarcoglycan1 test
  • Qualitative or quantitative defects of delta-sarcoglycan1 test
  • Qualitative or quantitative defects of dysferlin1 test
  • Qualitative or quantitative defects of dystrophin1 test
  • Reduced coagulation factor V activity1 test
  • Renal carnitine transport defect2 tests
  • Retinitis pigmentosa 391 test
  • Rhizomelic chondrodysplasia punctata type 12 tests
  • Salla disease2 tests
  • Sandhoff disease1 test
  • Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency1 test
  • Severe X-linked myotubular myopathy1 test
  • Sj√∂gren-Larsson syndrome2 tests
  • Smith-Lemli-Opitz syndrome2 tests
  • Spinal muscular atrophy2 tests
  • Spondylocostal dysostosis1 test
  • Spondylocostal dysostosis 1, autosomal recessive1 test
  • Spondylocostal dysostosis 2, autosomal recessive1 test
  • Spongy degeneration of central nervous system2 tests
  • Sulfate transporter-related osteochondrodysplasia2 tests
  • Tay-Sachs disease2 tests
  • Thrombophilia due to activated protein C resistance1 test
  • Trastuzumab emtansine response1 test
  • Trastuzumab response1 test
  • Trisomy 11 mosaicism1 test
  • Trisomy 181 test
  • Trisomy 61 test
  • Trisomy 81 test
  • Trisomy 91 test
  • Trisomy X syndrome1 test
  • Tuberous sclerosis syndrome2 tests
  • Turner syndrome1 test
  • Tyrosinemia type I2 tests
  • Tyrosinemia type II1 test
  • Usher syndrome type 11 test
  • Usher syndrome type 1C1 test
  • Usher syndrome type 1F2 tests
  • Usher syndrome type 2A1 test
  • Usher syndrome type 32 tests
  • Vemurafenib response1 test
  • Very long chain acyl-CoA dehydrogenase deficiency1 test
  • Von Hippel-Lindau syndrome2 tests
  • Walker-Warburg congenital muscular dystrophy3 tests
  • Wilson disease2 tests
  • Wolman disease1 test
  • X-linked Alport syndrome1 test
  • X-linked severe combined immunodeficiency1 test
  • Xeroderma pigmentosum group A1 test
  • Xeroderma pigmentosum, group C1 test
  • Young adult-onset distal hereditary motor neuropathy1 test

List of services

  • This lab has no services.

List of certifications/licenses

Certifications

  • CLIAHelp, Number: 05D1102604, Expiration date: 2024-08-07
  • CAP, Number: 7519776, Expiration date: 2024-03-23

Licenses

  • CA - California Department of Public Health CDPH, Number: CDF00338555, Expiration date: 2023-04-04
  • MD - Maryland Department of Health and Mental Hygiene DHMH, Number: 1642, Effective date: 2020-12-01 Non-expiring
  • NY - New York State Department of Health NYSDOH, Number: PFI: 8535, Expiration date: 2023-06-30
  • PA - Pennsylvania Department of Health PADOH, Number: 31837, Expiration date: 2023-08-15
  • RI - State of Rhode Island Department of Health RIDOH, Number: LCO01281, Expiration date: 2022-12-30

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.